Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1341 of 5804
-
New imaging test may help doctors spot real tumor growth in kids with brain cancer
Diagnosis Recruiting nowThe purpose of this study is to see if 18F-fluciclovine (Axumin®) PET imaging is useful and safe in the management of children with High Grade Gliomas. Investigators seek to determine if this imaging will help doctors tell the difference between tumor growth (progression) and oth…
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Triple-Drug attack targets Hard-to-Treat leukemias
Disease control Recruiting nowTo find the recommended doses of lisaftoclax and olverembatinib that can be given in combination with decitabine to participants with advanced CML and Ph+ AML.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a smartphone app ease the burden of advanced lung cancer?
Symptom relief Recruiting nowMulti-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Experimental CAR-T therapy takes aim at Hard-to-Treat scleroderma
Disease control OngoingA Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects with Systemic Sclerosis
Phase: PHASE1, PHASE2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug XB010 takes on advanced cancers in first human trial
Disease control Recruiting nowThis is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with pembrolizumab in subjects with locally advanced or metastatic solid tumors for whom alternative therapies do not …
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Anti-Aging cocktail shows promise in small pilot study
Disease control CompletedThis pilot study evaluated a multi-modal longevity protocol combining lifestyle optimisation, nutritional supplementation, and autologous cell-free conditioned media derived from peripheral blood-derived pro-regenerative cells (APRC-CM). Fourteen healthy adult participants comple…
Phase: NA • Sponsor: BlueBird Age Reversal SA • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill could help control high cholesterol Long-Term
Disease control OngoingThis is an extension study to evaluate the longer-term safety and efficacy of enlicitide decanoate in adults with hypercholesterolemia who completed either study MK-0616-013 (NCT05952856), study MK-0616-017 (NCT05952869), or study MK-0616-018 (NCT06450366).
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a Sibling-Focused program shield displaced girls from anxiety and depression?
Prevention CompletedForcibly displaced adolescents face increased risks for mental illness and distress, with adolescent girls disproportionately affected in part due to the heightened gender inequity that often accompanies forced displacement. Although the family unit has the potential to prevent m…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Heart attack patients may ditch aspirin sooner with new drug cocktail
Disease control Recruiting nowThe previous Mono Antiplatelet and Colchicine Therapy (MACT) pilot study (NCT04949516) demonstrated that it was feasible to discontinue aspirin therapy and administer low-dose colchicine on the day after percutaneous coronary intervention (PCI) in addition to potent P2Y12 inhibit…
Phase: PHASE4 • Sponsor: CHA University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple scan reveal the most dangerous form of colon cancer?
Diagnosis Recruiting nowColorectal cancer (CRC) is the 3rd most common cancer worldwide and accounts for \~14,000 new diagnoses and \~5,000 deaths in the Netherlands yearly (1.9 million and 935 thousand on a global level). Large scale transcriptional profiling of primary CRC tumors has revealed the pres…
Phase: NA • Sponsor: UMC Utrecht • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Blood test may spot bone fracture risk better than X-Rays
Diagnosis Recruiting nowOsteoporosis (OP) is one of most common age-associated and chronic metabolic bone diseases, featured by a decrease of bone mineral density (BMD) that increases the risk of bone fractures.OP guidelines agree that Dual-X-ray Absorptiometry (DXA) is the gold standard for BMD assessm…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New antibody trial aims to ease core autism symptoms
Symptom relief Recruiting nowMultisite 14-week prospective double-blind placebo controlled parallel-group randomized clinical trial with 14-week open-label extension at the end of double-blind treatment phase for placebo subjects. Eligible subjects will be randomized within each site in 2:1 ratio to receive …
Phase: PHASE2 • Sponsor: Rossignol Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New PET scans could sharpen bladder cancer diagnosis
Diagnosis Recruiting nowThe aim of this trial is to investigate the value of FAPI PET/MRI, FDG PET/MRI and MRI in diagnosing MIBC and predicting the efficacy of neoadjuvant therapy for MIBC patients, so as to guide the clinic to adjust the treatment plan in time and benefit MIBC patients.
Phase: NA • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New Dual-Action heart procedure could tame stubborn AFib
Disease control Recruiting nowA randomised controlled clinical trial to assess efficacy of convergent ablation with the LARIAT procedure, as compared to standard endocardial catheter ablation in patients with long-standing persistent atrial fibrillation (AF).
Phase: NA • Sponsor: Barts & The London NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Brain tumor DNA test could match kids to smarter treatments
Knowledge-focused Recruiting nowThe goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult patients who have been newly diagnosed with a high-grade glioma. This molecular profiling will decide if patients are eligible to participate in a subsequent treatm…
Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New heart procedure could replace pacemakers for fainting patients
Disease control Recruiting nowThe CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacem…
Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:46 UTC
-
Teachers fight germs: hygiene campaign cuts Kids' illnesses in lagos schools
Prevention CompletedChildren are considered as the most vulnerable group of individuals affected by lack of water, sanitation and hygiene facilities which predisposes them to a wide range of enteric diseases particularly diarrhoeal and parasitic infections. School-based WASH interventions typically …
Phase: NA • Sponsor: The Neo Child Initiative for Africa • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Baby's own poop could be the key to reversing antibiotic damage
Disease control Recruiting nowAntibiotics are lifesaving therapeutic drugs which have been used by adults, children, and infants alike for decades. There is an increase in global use of antibiotics over the course of lifetime and earlier in lifetime, with some countries recording as high as 12 courses a year …
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Gene therapy shot aims to fix gaucher disease in kids
Disease control OngoingThe purpose of this study was to evaluate the safety, tolerability, efficacy, immunogenicity, PD and PK characteristics of LY-M001 injection in children with GD1 aged 6 years ≤ age \< 18 years. This study mainly includes the main study stage and the long-term follow-up study stag…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can better coordination save lives? VA tests intensive case management for veterans at risk of suicide
Symptom relief Recruiting nowThe goal of this randomized clinical trial is to build the evidence base for SUPERCEDE, a suicide prevention focused intensive case management intervention to increase access, improve care coordination, provide suicide prevention monitoring, and procure a timely response of VA me…
Phase: NA • Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC